Exploring the OncoGenomic Landscape of cancer
Accurate comparison and analysis of genomic data is crucial to the advancement of precision oncology. The authors of a recently published article in Genome… Read more »
Lídia Mateo, Oriol Guitart, Dr Miquel Duran-Frigola & Dr. Patrick Aloy.
Lídia Mateo, MSc is a PhD student in the Structural Bioinformatics and Network Biology (SB&NB) lab at the Institute for Research in Biomedicine (IRB Barcelona). Her research is focused in the development of computational strategies to enable precision oncology.
Oriol Guitart, BSE is a Research Assistant at IRB Barcelona, responsible for the implementation and maintenance of all the computational resources of the SB&NB lab, and develops of novel strategies to visualize complex biological and chemical data.
Dr Miquel Duran-Frigola is a Research Associate in the SB&NB lab at IRB Barcelona. With a background in Chemistry and Bioinformatics, his research interests lay at the intersection between small-molecule drug discovery and large-scale biological data analysis.
Dr Patrick Aloy is and ICREA Research Professor, and head of the SB&NB lab at IRB Barcelona. The main goal of his laboratory is to combine computational and cell biology with chemo-centric approaches to unveil the basic functioning of physio-pathological pathways and improve the drug discovery process.
Oriol Guitart, BSE is a Research Assistant at IRB Barcelona, responsible for the implementation and maintenance of all the computational resources of the SB&NB lab, and develops of novel strategies to visualize complex biological and chemical data.
Dr Miquel Duran-Frigola is a Research Associate in the SB&NB lab at IRB Barcelona. With a background in Chemistry and Bioinformatics, his research interests lay at the intersection between small-molecule drug discovery and large-scale biological data analysis.
Dr Patrick Aloy is and ICREA Research Professor, and head of the SB&NB lab at IRB Barcelona. The main goal of his laboratory is to combine computational and cell biology with chemo-centric approaches to unveil the basic functioning of physio-pathological pathways and improve the drug discovery process.
Latest posts by Lídia Mateo, Oriol Guitart, Dr Miquel Duran-Frigola & Dr. Patrick Aloy. (see all)
- Exploring the OncoGenomic Landscape of cancer - 20th August 2018